| LÁZNIČKOVÁ, Petra, Tomáš KEPÁK, Marcela HORTOVÁ KOHOUTKOVÁ, Luděk HORVÁTH, Kateřina SHEARDOVÁ, Rafał MARCINIAK, Carmine VACCA, Michaela SIKLOVA, Teresa ZELANTE, Lenka ROSSMEISLOVA, Zdenka KŘENOVÁ, Jaroslav ŠTĚRBA, Kamila BENDICKOVA a Jan FRIČ. Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence. EUROPEAN JOURNAL OF IMMUNOLOGY. HOBOKEN: WILEY, 2020, roč. 50, č. 12, s. 2092-2094. ISSN 0014-2980. Dostupné z: https://dx.doi.org/10.1002/eji.202048541. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1676816,
author = {Lázničková, Petra and Kepák, Tomáš and Hortová Kohoutková, Marcela and Horváth, Luděk and Sheardová, Kateřina and Marciniak, Rafał and Vacca, Carmine and Siklova, Michaela and Zelante, Teresa and Rossmeislova, Lenka and Křenová, Zdenka and Štěrba, Jaroslav and Bendickova, Kamila and Frič, Jan},
article_location = {HOBOKEN},
article_number = {12},
doi = {http://dx.doi.org/10.1002/eji.202048541},
keywords = {adverse late effects; childhood; immune recovery; immunosenescence; neuroblastoma},
language = {eng},
issn = {0014-2980},
journal = {EUROPEAN JOURNAL OF IMMUNOLOGY},
title = {Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence},
url = {https://onlinelibrary.wiley.com/doi/full/10.1002/eji.202048541},
volume = {50},
year = {2020}
}
TY - JOUR
ID - 1676816
AU - Lázničková, Petra - Kepák, Tomáš - Hortová Kohoutková, Marcela - Horváth, Luděk - Sheardová, Kateřina - Marciniak, Rafał - Vacca, Carmine - Siklova, Michaela - Zelante, Teresa - Rossmeislova, Lenka - Křenová, Zdenka - Štěrba, Jaroslav - Bendickova, Kamila - Frič, Jan
PY - 2020
TI - Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence
JF - EUROPEAN JOURNAL OF IMMUNOLOGY
VL - 50
IS - 12
SP - 2092-2094
EP - 2092-2094
PB - WILEY
SN - 00142980
KW - adverse late effects
KW - childhood
KW - immune recovery
KW - immunosenescence
KW - neuroblastoma
UR - https://onlinelibrary.wiley.com/doi/full/10.1002/eji.202048541
L2 - https://onlinelibrary.wiley.com/doi/full/10.1002/eji.202048541
N2 - Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8(+)T cell compartment and elevated plasma TNF-alpha but in later follow-up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors.
ER -
LÁZNIČKOVÁ, Petra, Tomáš KEPÁK, Marcela HORTOVÁ KOHOUTKOVÁ, Luděk HORVÁTH, Kateřina SHEARDOVÁ, Rafał MARCINIAK, Carmine VACCA, Michaela SIKLOVA, Teresa ZELANTE, Lenka ROSSMEISLOVA, Zdenka KŘENOVÁ, Jaroslav ŠTĚRBA, Kamila BENDICKOVA a Jan FRIČ. Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence. \textit{EUROPEAN JOURNAL OF IMMUNOLOGY}. HOBOKEN: WILEY, 2020, roč.~50, č.~12, s.~2092-2094. ISSN~0014-2980. Dostupné z: https://dx.doi.org/10.1002/eji.202048541.
|
